More than 180 years ago, James Parkinson first described thedisorder that bears his name, and 30 years ago levodopa, stillthe most effective therapy, was introduced. Parkinson's diseaseis a neurodegenerative disorder of unknown cause that affectsover 1 million people in North America. Age is the single mostconsistent risk factor, and with the increasing age of the generalpopulation, the prevalence of Parkinson's disease will risesteadily in the future. The impact of the disease is indicatedby the fact that mortality is two to five times as high amongaffected persons as among age-matched controls,1,2,3 resulting. . . [Full Text of this Article]
Diagnosis and Clinical Features
Pathological Findings
Pathogenesis and Mechanisms of Cell Death
Mitochondrial Dysfunction and Oxidative Metabolism
Excitotoxins
Neurotrophic Factors
Immune Factors
Epidemiology and Genetics
References
This article has been cited by other articles:
Visanji, N. P., Orsi, A., Johnston, T. H., Howson, P. A., Dixon, K., Callizot, N., Brotchie, J. M., Rees, D. D.
(2008). PYM50028, a novel, orally active, nonpeptide neurotrophic factor inducer, prevents and reverses neuronal damage induced by MPP+ in mesencephalic neurons and by MPTP in a mouse model of Parkinson's disease. FASEB J.
22: 2488-2497
[Abstract][Full Text]
Marras, C., Lang, A.
(2008). Invited Article: Changing concepts in Parkinson disease: Moving beyond the Decade of the Brain. Neurology
70: 1996-2003
[Abstract][Full Text]
Bousquet, M., Saint-Pierre, M., Julien, C., Salem, N. Jr., Cicchetti, F., Calon, F.
(2008). Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease. FASEB J.
22: 1213-1225
[Abstract][Full Text]
Lee, J. T., Wheeler, T. C., Li, L., Chin, L.-S.
(2008). Ubiquitination of {alpha}-synuclein by Siah-1 promotes {alpha}-synuclein aggregation and apoptotic cell death. Hum Mol Genet
17: 906-917
[Abstract][Full Text]
Schenkman, M., Hall, D., Kumar, R., Kohrt, W. M
(2008). Endurance Exercise Training to Improve Economy of Movement of People With Parkinson Disease: Three Case Reports. ptjournal
88: 63-76
[Abstract][Full Text]
Chan, L-L, Rumpel, H, Yap, K, Lee, E, Loo, H-V, Ho, G-L, Fook-Chong, S, Yuen, Y, Tan, E-K
(2007). Case control study of diffusion tensor imaging in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry
78: 1383-1386
[Abstract][Full Text]
Wassef, R., Haenold, R., Hansel, A., Brot, N., Heinemann, S. H., Hoshi, T.
(2007). Methionine Sulfoxide Reductase A and a Dietary Supplement S-Methyl-L-Cysteine Prevent Parkinson's-Like Symptoms. J. Neurosci.
27: 12808-12816
[Abstract][Full Text]
Pan, S., Shi, M., Jin, J., Albin, R. L., Lieberman, A., Gearing, M., Lin, B., Pan, C., Yan, X., Kashima, D. T., Zhang, J.
(2007). Proteomics Identification of Proteins in Human Cortex Using Multidimensional Separations and MALDI Tandem Mass Spectrometer. Mol. Cell. Proteomics
6: 1818-1823
[Abstract][Full Text]
Uc, E. Y., Rizzo, M., Anderson, S. W., Sparks, J. D., Rodnitzky, R. L., Dawson, J. D.
(2007). Impaired navigation in drivers with Parkinson's disease. Brain
130: 2433-2440
[Abstract][Full Text]
Herrera, F. E., Zucchelli, S., Jezierska, A., Lavina, Z. S., Gustincich, S., Carloni, P.
(2007). On the Oligomeric State of DJ-1 Protein and Its Mutants Associated with Parkinson Disease: A COMBINED COMPUTATIONAL AND IN VITRO STUDY. J. Biol. Chem.
282: 24905-24914
[Abstract][Full Text]
Storch, A., Jost, W. H., Vieregge, P., Spiegel, J., Greulich, W., Durner, J., Muller, T., Kupsch, A., Henningsen, H., Oertel, W. H., Fuchs, G., Kuhn, W., Niklowitz, P., Koch, R., Herting, B., Reichmann, H., for the German Coenzyme Q10 Study Group,
(2007). Randomized, Double-blind, Placebo-Controlled Trial on Symptomatic Effects of Coenzyme Q10 in Parkinson Disease. Arch Neurol
64: 938-944
[Abstract][Full Text]
Peng, J., Peng, L., Stevenson, F. F., Doctrow, S. R., Andersen, J. K.
(2007). Iron and Paraquat as Synergistic Environmental Risk Factors in Sporadic Parkinson's Disease Accelerate Age-Related Neurodegeneration. J. Neurosci.
27: 6914-6922
[Abstract][Full Text]
Mitsumoto, Y.
(2007). Mitochondrial Nutrition as a Strategy for Neuroprotection in Parkinson's Disease--Research Focus in the Department of Alternative Medicine and Experimental Therapeutics at Hokuriku University. Evid Based Complement Alternat Med
4: 263-265
[Full Text]
Stefani, A., Lozano, A. M., Peppe, A., Stanzione, P., Galati, S., Tropepi, D., Pierantozzi, M., Brusa, L., Scarnati, E., Mazzone, P.
(2007). Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain
130: 1596-1607
[Abstract][Full Text]
Marchitti, S. A., Deitrich, R. A., Vasiliou, V.
(2007). Neurotoxicity and Metabolism of the Catecholamine-Derived 3,4-Dihydroxyphenylacetaldehyde and 3,4-Dihydroxyphenylglycolaldehyde: The Role of Aldehyde Dehydrogenase. Pharmacol. Rev.
59: 125-150
[Abstract][Full Text]
Aamodt, A. H., Stovner, L. J., Thorstensen, K., Lydersen, S., White, L. R, Aasly, J. O
(2007). Prevalence of haemochromatosis gene mutations in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry
78: 315-317
[Abstract][Full Text]
Vernon, A. C., Zbarsky, V., Datla, K. P., Dexter, D. T., Croucher, M. J.
(2007). Selective Activation of Group III Metabotropic Glutamate Receptors by L-(+)-2-Amino-4-phosphonobutryic Acid Protects the Nigrostriatal System against 6-Hydroxydopamine Toxicity in Vivo. J. Pharmacol. Exp. Ther.
320: 397-409
[Abstract][Full Text]
Yasuhara, T., Matsukawa, N., Hara, K., Yu, G., Xu, L., Maki, M., Kim, S. U., Borlongan, C. V.
(2006). Transplantation of Human Neural Stem Cells Exerts Neuroprotection in a Rat Model of Parkinson's Disease. J. Neurosci.
26: 12497-12511
[Abstract][Full Text]
Uc, E. Y., Rizzo, M., Anderson, S. W., Sparks, J. D., Rodnitzky, R. L., Dawson, J. D.
(2006). Driving with distraction in Parkinson disease. Neurology
67: 1774-1780
[Abstract][Full Text]
Peng, J., Xie, L., Stevenson, F. F., Melov, S., Di Monte, D. A., Andersen, J. K.
(2006). Nigrostriatal Dopaminergic Neurodegeneration in the Weaver Mouse Is Mediated via Neuroinflammation and Alleviated by Minocycline Administration.. J. Neurosci.
26: 11644-11651
[Abstract][Full Text]
DI MATTEO, V., BENIGNO, A., PIERUCCI, M., GIULIANO, D. A., CRESCIMANNO, G., ESPOSITO, E., DI GIOVANNI, G.
(2006). 7-Nitroindazole Protects Striatal Dopaminergic Neurons against MPP+-Induced Degeneration: An in Vivo Microdialysis Study. Ann. N. Y. Acad. Sci.
1089: 462-471
[Abstract][Full Text]
Jiang, Q., Yan, Z., Feng, J.
(2006). Neurotrophic Factors Stabilize Microtubules and Protect against Rotenone Toxicity on Dopaminergic Neurons. J. Biol. Chem.
281: 29391-29400
[Abstract][Full Text]
Wang, D., Qian, L., Xiong, H., Liu, J., Neckameyer, W. S., Oldham, S., Xia, K., Wang, J., Bodmer, R., Zhang, Z.
(2006). From the Cover: Antioxidants protect PINK1-dependent dopaminergic neurons in Drosophila. Proc. Natl. Acad. Sci. USA
103: 13520-13525
[Abstract][Full Text]
Bier, E.
(2006). Antioxidants put Parkinson flies back in the PINK. Proc. Natl. Acad. Sci. USA
103: 13269-13270
[Full Text]
Meulener, M. C., Xu, K., Thomson, L., Ischiropoulos, H., Bonini, N. M.
(2006). Mutational analysis of DJ-1 in Drosophila implicates functional inactivation by oxidative damage and aging. Proc. Natl. Acad. Sci. USA
103: 12517-12522
[Abstract][Full Text]
Tanji, K., Tanaka, T., Mori, F., Kito, K., Takahashi, H., Wakabayashi, K., Kamitani, T.
(2006). NUB1 Suppresses the Formation of Lewy Body-Like Inclusions by Proteasomal Degradation of Synphilin-1. Am. J. Pathol.
169: 553-565
[Abstract][Full Text]
Zhong, N., Kim, C. Y., Rizzu, P., Geula, C., Porter, D. R., Pothos, E. N., Squitieri, F., Heutink, P., Xu, J.
(2006). DJ-1 Transcriptionally Up-regulates the Human Tyrosine Hydroxylase by Inhibiting the Sumoylation of Pyrimidine Tract-binding Protein-associated Splicing Factor. J. Biol. Chem.
281: 20940-20948
[Abstract][Full Text]
Davidson, P. S. R., Anaki, D., Saint-Cyr, J. A., Chow, T. W., Moscovitch, M.
(2006). Exploring the recognition memory deficit in Parkinson's disease: estimates of recollection versus familiarity. Brain
129: 1768-1779
[Abstract][Full Text]
Raiteri, M.
(2006). Functional pharmacology in human brain.. Pharmacol. Rev.
58: 162-193
[Abstract][Full Text]
Tang, B., Xiong, H., Sun, P., Zhang, Y., Wang, D., Hu, Z., Zhu, Z., Ma, H., Pan, Q., Xia, J.-h., Xia, K., Zhang, Z.
(2006). Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease. Hum Mol Genet
15: 1816-1825
[Abstract][Full Text]
McNaught, K. St. P., Jackson, T., JnoBaptiste, R., Kapustin, A., Olanow, C. W.
(2006). Proteasomal dysfunction in sporadic Parkinson's disease. Neurology
66: S37-S49
[Abstract][Full Text]
Jiang, Q., Yan, Z., Feng, J.
(2006). Activation of group III metabotropic glutamate receptors attenuates rotenone toxicity on dopaminergic neurons through a microtubule-dependent mechanism.. J. Neurosci.
26: 4318-4328
[Abstract][Full Text]
von Coelln, R., Thomas, B., Andrabi, S. A., Lim, K. L., Savitt, J. M., Saffary, R., Stirling, W., Bruno, K., Hess, E. J., Lee, M. K., Dawson, V. L., Dawson, T. M.
(2006). Inclusion body formation and neurodegeneration are parkin independent in a mouse model of alpha-synucleinopathy.. J. Neurosci.
26: 3685-3696
[Abstract][Full Text]
Gardoni, F., Picconi, B., Ghiglieri, V., Polli, F., Bagetta, V., Bernardi, G., Cattabeni, F., Di Luca, M., Calabresi, P.
(2006). A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia.. J. Neurosci.
26: 2914-2922
[Abstract][Full Text]
Zhou, W., Freed, C. R.
(2005). DJ-1 Up-regulates Glutathione Synthesis during Oxidative Stress and Inhibits A53T {alpha}-Synuclein Toxicity. J. Biol. Chem.
280: 43150-43158
[Abstract][Full Text]
Uc, E. Y., Rizzo, M., Anderson, S. W., Qian, S., Rodnitzky, R. L., Dawson, J. D.
(2005). Visual dysfunction in Parkinson disease without dementia. Neurology
65: 1907-1913
[Abstract][Full Text]
Shen, H.-Y., He, J.-C., Wang, Y., Huang, Q.-Y., Chen, J.-F.
(2005). Geldanamycin Induces Heat Shock Protein 70 and Protects against MPTP-induced Dopaminergic Neurotoxicity in Mice. J. Biol. Chem.
280: 39962-39969
[Abstract][Full Text]
Goldwurm, S, Fonzo, A D., Simons, E J, Rohe, C F, Zini, M, Canesi, M, Tesei, S, Zecchinelli, A, Antonini, A, Mariani, C, Meucci, N, Sacilotto, G, Sironi, F, Salani, G, Ferreira, J, Chien, H F, Fabrizio, E, Vanacore, N, Libera, A D., Stocchi, F, Diroma, C, Lamberti, P, Sampaio, C, Meco, G, Barbosa, E, Bertoli-Avella, A M, Breedveld, G J, Oostra, B A, Pezzoli, G, Bonifati, V
(2005). The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor. J. Med. Genet.
42: e65-e65
[Abstract][Full Text]
Petit, A., Kawarai, T., Paitel, E., Sanjo, N., Maj, M., Scheid, M., Chen, F., Gu, Y., Hasegawa, H., Salehi-Rad, S., Wang, L., Rogaeva, E., Fraser, P., Robinson, B., St George-Hyslop, P., Tandon, A.
(2005). Wild-type PINK1 Prevents Basal and Induced Neuronal Apoptosis, a Protective Effect Abrogated by Parkinson Disease-related Mutations. J. Biol. Chem.
280: 34025-34032
[Abstract][Full Text]
Sriram, S. R., Li, X., Ko, H. S., Chung, K. K.K., Wong, E., Lim, K. L., Dawson, V. L., Dawson, T. M.
(2005). Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin. Hum Mol Genet
14: 2571-2586
[Abstract][Full Text]
Peng, J., Stevenson, F. F., Doctrow, S. R., Andersen, J. K.
(2005). Superoxide Dismutase/Catalase Mimetics Are Neuroprotective against Selective Paraquat-mediated Dopaminergic Neuron Death in the Substantial Nigra: IMPLICATIONS FOR PARKINSON DISEASE. J. Biol. Chem.
280: 29194-29198
[Abstract][Full Text]
Savitt, J. M., Jang, S. S., Mu, W., Dawson, V. L., Dawson, T. M.
(2005). Bcl-x Is Required for Proper Development of the Mouse Substantia Nigra. J. Neurosci.
25: 6721-6728
[Abstract][Full Text]
Cha, G.-H., Kim, S., Park, J., Lee, E., Kim, M., Lee, S. B., Kim, J. M., Chung, J., Cho, K. S.
(2005). Parkin negatively regulates JNK pathway in the dopaminergic neurons of Drosophila. Proc. Natl. Acad. Sci. USA
102: 10345-10350
[Abstract][Full Text]
Zhang, L., Shimoji, M., Thomas, B., Moore, D. J., Yu, S.-W., Marupudi, N. I., Torp, R., Torgner, I. A., Ottersen, O. P., Dawson, T. M., Dawson, V. L.
(2005). Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis. Hum Mol Genet
14: 2063-2073
[Abstract][Full Text]
Norris, E. H., Giasson, B. I., Hodara, R., Xu, S., Trojanowski, J. Q., Ischiropoulos, H., Lee, V. M.-Y.
(2005). Reversible Inhibition of {alpha}-Synuclein Fibrillization by Dopaminochrome-mediated Conformational Alterations. J. Biol. Chem.
280: 21212-21219
[Abstract][Full Text]
Stocchi, F., Vacca, L., Ruggieri, S., Olanow, C. W.
(2005). Intermittent vs Continuous Levodopa Administration in Patients With Advanced Parkinson Disease: A Clinical and Pharmacokinetic Study. Arch Neurol
62: 905-910
[Abstract][Full Text]
Bonneville, F., Welter, M. L., Elie, C., du Montcel, S. T., Hasboun, D., Menuel, C., Houeto, J. L., Bonnet, A. M., Mesnage, V., Pidoux, B., Navarro, S., Cornu, P., Agid, Y., Dormont, D.
(2005). Parkinson disease, brain volumes, and subthalamic nucleus stimulation. Neurology
64: 1598-1604
[Abstract][Full Text]
Callio, J., Oury, T. D., Chu, C. T.
(2005). Manganese Superoxide Dismutase Protects against 6-Hydroxydopamine Injury in Mouse Brains. J. Biol. Chem.
280: 18536-18542
[Abstract][Full Text]
Kim, R. H., Smith, P. D., Aleyasin, H., Hayley, S., Mount, M. P., Pownall, S., Wakeham, A., You-Ten, A. J., Kalia, S. K., Horne, P., Westaway, D., Lozano, A. M., Anisman, H., Park, D. S., Mak, T. W.
(2005). Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc. Natl. Acad. Sci. USA
102: 5215-5220
[Abstract][Full Text]
Zhong, L., Tan, Y., Zhou, A., Yu, Q., Zhou, J.
(2005). RING Finger Ubiquitin-Protein Isopeptide Ligase Nrdp1/FLRF Regulates Parkin Stability and Activity. J. Biol. Chem.
280: 9425-9430
[Abstract][Full Text]
Boska, M. D., Lewis, T. B., Destache, C. J., Benner, E. J., Nelson, J. A., Uberti, M., Mosley, R. L., Gendelman, H. E.
(2005). Quantitative 1H Magnetic Resonance Spectroscopic Imaging Determines Therapeutic Immunization Efficacy in an Animal Model of Parkinson's Disease. J. Neurosci.
25: 1691-1700
[Abstract][Full Text]
Sienkiewicz-Jarosz, H, Scinska, A, Kuran, W, Ryglewicz, D, Rogowski, A, Wrobel, E, Korkosz, A, Kukwa, A, Kostowski, W, Bienkowski, P
(2005). Taste responses in patients with Parkinson's disease. J. Neurol. Neurosurg. Psychiatry
76: 40-46
[Abstract][Full Text]
Moore, D. J., Zhang, L., Troncoso, J., Lee, M. K., Hattori, N., Mizuno, Y., Dawson, T. M., Dawson, V. L.
(2005). Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress. Hum Mol Genet
14: 71-84
[Abstract][Full Text]
Jiang, H., Jiang, Q., Feng, J.
(2004). Parkin Increases Dopamine Uptake by Enhancing the Cell Surface Expression of Dopamine Transporter. J. Biol. Chem.
279: 54380-54386
[Abstract][Full Text]
Amirnovin, R., Williams, Z. M., Cosgrove, G. R., Eskandar, E. N.
(2004). Visually Guided Movements Suppress Subthalamic Oscillations in Parkinson's Disease Patients. J. Neurosci.
24: 11302-11306
[Abstract][Full Text]
Ohtake, H., Limprasert, P., Fan, Y., Onodera, O., Kakita, A., Takahashi, H., Bonner, L. T., Tsuang, D. W., Murray, I. V.J., Lee, V. M.-Y., Trojanowski, J. Q., Ishikawa, A., Idezuka, J., Murata, M., Toda, T., Bird, T. D., Leverenz, J. B., Tsuji, S., La Spada, A. R.
(2004). {beta}-Synuclein gene alterations in dementia with Lewy bodies. Neurology
63: 805-811
[Abstract][Full Text]
Aubin, N., Barneoud, P., Carter, C., Caille, D., Sontag, N., Marc, C., Lolivier, J., Gardes, A., Perron, C., Le Kim, A., Charieras, T., Pandini, M., Burnier, P., Puech, F., Jegham, S., George, P., Scatton, B., Curet, O.
(2004). SL25.1131 [3(S),3a(S)-3-Methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a New, Reversible, and Mixed Inhibitor of Monoamine Oxidase-A and Monoamine Oxidase-B: Biochemical and Behavioral Profile. J. Pharmacol. Exp. Ther.
310: 1171-1182
[Abstract][Full Text]
Grabli, D., McCairn, K., Hirsch, E. C., Agid, Y., Feger, J., Francois, C., Tremblay, L.
(2004). Behavioural disorders induced by external globus pallidus dysfunction in primates: I. Behavioural study. Brain
127: 2039-2054
[Abstract][Full Text]
Schlossmacher, M. G., Hamann, C., Cole, A. G., Gonzalez, R. G., Frosch, M. P.
(2004). Case 27-2004 - A 79-Year-Old Woman with Disturbances in Gait, Cognition, and Autonomic Function. NEJM
351: 912-922
[Full Text]
Peng, J., Mao, X. O., Stevenson, F. F., Hsu, M., Andersen, J. K.
(2004). The Herbicide Paraquat Induces Dopaminergic Nigral Apoptosis through Sustained Activation of the JNK Pathway. J. Biol. Chem.
279: 32626-32632
[Abstract][Full Text]
von Coelln, R., Thomas, B., Savitt, J. M., Lim, K. L., Sasaki, M., Hess, E. J., Dawson, V. L., Dawson, T. M.
(2004). Loss of locus coeruleus neurons and reduced startle in parkin null mice. Proc. Natl. Acad. Sci. USA
101: 10744-10749
[Abstract][Full Text]
Tai, Y F, Piccini, P
(2004). Applications of positron emission tomography (PET) in neurology. J. Neurol. Neurosurg. Psychiatry
75: 669-676
[Abstract][Full Text]
Mata, I. F., Lockhart, P. J., Farrer, M. J.
(2004). Parkin genetics: one model for Parkinson's disease. Hum Mol Genet
13: R127-133
[Abstract][Full Text]
Spanaki, C., Plaitakis, A.
(2004). Bilineal transmission of Parkinson disease on Crete suggests a complex inheritance. Neurology
62: 815-817
[Abstract][Full Text]
Olanow, C W.
(2004). Manganese-Induced Parkinsonism and Parkinson's Disease. Ann. N. Y. Acad. Sci.
1012: 209-223
[Abstract][Full Text]
Olzmann, J. A., Brown, K., Wilkinson, K. D., Rees, H. D., Huai, Q., Ke, H., Levey, A. I., Li, L., Chin, L.-S.
(2004). Familial Parkinson's Disease-associated L166P Mutation Disrupts DJ-1 Protein Folding and Function. J. Biol. Chem.
279: 8506-8515
[Abstract][Full Text]
Hedrich, K., Djarmati, A., Schafer, N., Hering, R., Wellenbrock, C., Weiss, P. H., Hilker, R., Vieregge, P., Ozelius, L. J., Heutink, P., Bonifati, V., Schwinger, E., Lang, A. E., Noth, J., Bressman, S. B., Pramstaller, P. P., Riess, O., Klein, C.
(2004). DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease. Neurology
62: 389-394
[Abstract][Full Text]
Stocchi, F., Olanow, C. W.
(2004). Continuous dopaminergic stimulation in early and advanced Parkinson's disease. Neurology
62: S56-63
[Abstract][Full Text]
Olanow, C. W., Stocchi, F.
(2004). COMT inhibitors in Parkinson's disease: Can they prevent and/or reverse levodopa-induced motor complications?. Neurology
62: S72-81
[Abstract][Full Text]
Paradiso, G., Saint-Cyr, J. A., Lozano, A. M., Lang, A. E., Chen, R.
(2003). Involvement of the human subthalamic nucleus in movement preparation. Neurology
61: 1538-1545
[Abstract][Full Text]
Chen, J.-F., Fredduzzi, S., Bastia, E., Yu, L., Moratalla, R., Ongini, E., Schwarzschild, M. A.
(2003). Adenosine A2A receptors in neuroadaptation to repeated dopaminergic stimulation: Implications for the treatment of dyskinesias in Parkinson's disease. Neurology
61: S74-81
[Abstract][Full Text]
Shults, C. W.
(2003). Treatments of Parkinson Disease: Circa 2003. Arch Neurol
60: 1680-1684
[Abstract][Full Text]
Krack, P., Batir, A., Van Blercom, N., Chabardes, S., Fraix, V., Ardouin, C., Koudsie, A., Limousin, P. D., Benazzouz, A., LeBas, J. F., Benabid, A.-L., Pollak, P.
(2003). Five-Year Follow-up of Bilateral Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease. NEJM
349: 1925-1934
[Abstract][Full Text]
Macedo, M. G., Anar, B., Bronner, I. F., Cannella, M., Squitieri, F., Bonifati, V., Hoogeveen, A., Heutink, P., Rizzu, P.
(2003). The DJ-1L166P mutant protein associated with early onset Parkinson's disease is unstable and forms higher-order protein complexes. Hum Mol Genet
12: 2807-2816
[Abstract][Full Text]
Kennedy, R., Mittal, D., O'Jile, J.
(2003). Electroconvulsive Therapy in Movement Disorders: An Update. J. Neuropsychiatry Clin. Neurosi.
15: 407-421
[Abstract][Full Text]
Ardley, H. C., Scott, G. B., Rose, S. A., Tan, N. G. S., Markham, A. F., Robinson, P. A.
(2003). Inhibition of Proteasomal Activity Causes Inclusion Formation in Neuronal and Non-Neuronal Cells Overexpressing Parkin. Mol. Biol. Cell
14: 4541-4556
[Abstract][Full Text]
Fornai, F., Lenzi, P., Gesi, M., Ferrucci, M., Lazzeri, G., Busceti, C. L., Ruffoli, R., Soldani, P., Ruggieri, S., Alessandri, M. G., Paparelli, A.
(2003). Fine Structure and Biochemical Mechanisms Underlying Nigrostriatal Inclusions and Cell Death after Proteasome Inhibition. J. Neurosci.
23: 8955-8966
[Abstract][Full Text]
Wilson, M. A., Collins, J. L., Hod, Y., Ringe, D., Petsko, G. A.
(2003). The 1.1-A resolution crystal structure of DJ-1, the protein mutated in autosomal recessive early onset Parkinson's disease. Proc. Natl. Acad. Sci. USA
100: 9256-9261
[Abstract][Full Text]
Chen, H., Zhang, S. M., Hernan, M. A., Schwarzschild, M. A., Willett, W. C., Colditz, G. A., Speizer, F. E., Ascherio, A.
(2003). Nonsteroidal Anti-inflammatory Drugs and the Risk of Parkinson Disease. Arch Neurol
60: 1059-1064
[Abstract][Full Text]
Colosimo, C, Hughes, A J, Kilford, L, Lees, A J
(2003). Lewy body cortical involvement may not always predict dementia in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry
74: 852-856
[Abstract][Full Text]
Kahns, S., Kalai, M., Jakobsen, L. D., Clark, B. F. C., Vandenabeele, P., Jensen, P. H.
(2003). Caspase-1 and Caspase-8 Cleave and Inactivate Cellular Parkin. J. Biol. Chem.
278: 23376-23380
[Abstract][Full Text]
HAMANI, C., LOZANO, A. M.
(2003). Physiology and Pathophysiology of Parkinson's Disease. Ann. N. Y. Acad. Sci.
991: 15-21
[Abstract][Full Text]
TROJANOWSKI, J. Q., LEE, V. M-Y.
(2003). Parkinson's Disease and Related {alpha}-Synucleinopathies Are Brain Amyloidoses. Ann. N. Y. Acad. Sci.
991: 107-110
[Abstract][Full Text]
WANG, H., SHIMOJI, M., YU, S.-W., DAWSON, T. M., DAWSON, V. L.
(2003). Apoptosis Inducing Factor and PARP-Mediated Injury in the MPTP Mouse Model of Parkinson's Disease. Ann. N. Y. Acad. Sci.
991: 132-139
[Abstract][Full Text]
Seppi, K., Schocke, M.F.H., Esterhammer, R., Kremser, C., Brenneis, C., Mueller, J., Boesch, S., Jaschke, W., Poewe, W., Wenning, G.K.
(2003). Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy. Neurology
60: 922-927
[Abstract][Full Text]
Guttman, M., Kish, S. J., Furukawa, Y.
(2003). Current concepts in the diagnosis and management of Parkinson's disease. CMAJ
168: 293-301
[Abstract][Full Text]
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibanez, P., Joosse, M., van Dongen, J. W., Vanacore, N., van Swieten, J. C., Brice, A., Meco, G., van Duijn, C. M., Oostra, B. A., Heutink, P.
(2003). Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism. Science
299: 256-259
[Abstract][Full Text]
Toledo-Aral, J. J., Mendez-Ferrer, S., Pardal, R., Echevarria, M., Lopez-Barneo, J.
(2003). Trophic Restoration of the Nigrostriatal Dopaminergic Pathway in Long-Term Carotid Body-Grafted Parkinsonian Rats. J. Neurosci.
23: 141-148
[Abstract][Full Text]
Nicholson, G., Pereira, A. C., Hall, G. M.
(2002). Parkinson's disease and anaesthesia. Br J Anaesth
89: 904-916
[Abstract][Full Text]
Mayberg, H. S., Lozano, A. M.
(2002). Penfield revisited?: Understanding and modifying behavior by deep brain stimulation for PD. Neurology
59: 1298-1299
[Full Text]
Kulak, J. M., Musachio, J. L., McIntosh, J. M., Quik, M.
(2002). Declines in Different beta 2* Nicotinic Receptor Populations in Monkey Striatum after Nigrostriatal Damage. J. Pharmacol. Exp. Ther.
303: 633-639
[Abstract][Full Text]
Zhang, S.M., Hernan, M.A., Chen, H., Spiegelman, D., Willett, W.C., Ascherio, A.
(2002). Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk. Neurology
59: 1161-1169
[Abstract][Full Text]
Abbott, R. D., Ross, G. W., White, L. R., Nelson, J. S., Masaki, K. H., Tanner, C. M., Curb, J. D., Blanchette, P. L., Popper, J. S., Petrovitch, H.
(2002). Midlife adiposity and the future risk of Parkinson's disease. Neurology
59: 1051-1057
[Abstract][Full Text]
Grondin, R., Zhang, Z., Yi, A., Cass, W. A., Maswood, N., Andersen, A. H., Elsberry, D. D., Klein, M. C., Gerhardt, G. A., Gash, D. M.
(2002). Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys. Brain
125: 2191-2201
[Abstract][Full Text]
Chen, J.-F., Steyn, S., Staal, R., Petzer, J. P., Xu, K., Van der Schyf, C. J., Castagnoli, K., Sonsalla, P. K., Castagnoli, N. Jr., Schwarzschild, M. A.
(2002). 8-(3-Chlorostyryl)caffeine May Attenuate MPTP Neurotoxicity through Dual Actions of Monoamine Oxidase Inhibition and A2A Receptor Antagonism. J. Biol. Chem.
277: 36040-36044
[Abstract][Full Text]
Kahns, S., Lykkebo, S., Jakobsen, L. D., Nielsen, M. S., Jensen, P. H.
(2002). Caspase-mediated Parkin Cleavage in Apoptotic Cell Death. J. Biol. Chem.
277: 15303-15308
[Abstract][Full Text]
Previous
